A Review of Medications for PTSD, With a Focus on Topiramate
The Carlat Psychiatry Report, Volume 19, Number 5, May 2021
https://www.thecarlatreport.com/newsletter-issue/tcprv19n5/
Issue Links: Learning Objectives | Editorial Information
Topics: PTSD
Paul Riordan, MD.
Assistant Consulting Professor of Psychiatry, Duke University.
Dr. Riordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Topiramate is not first-line in PTSD, but it does have a role, particularly when alcohol use is part of the picture.
You can't view details of this content, please login or buy subscription here